|
In questo numero:
EDITORIALE
BISFOSFONATI 2000/2002
Paolo Filipponi, Sonia Cristallini, Giancarlo Policani
Umbertide (PG), U.O. di Medicina CROMAL (Centro Osteoporosi e Malattie dell’Apparato
Locomotore).
ABSTRACT
Abstract di articoli recentemente pubblicati, selezionati dal caporedattore e
completati da un commento editoriale.
The Amino Bisphosphonate Ibandronate Prevents Calciphylaxis in the Rat at Doses
that Inhibit Bone Resorption
Price PA, Omid N, Than TN et al.
Division of Biology, University of California
CALCIF TISSUE INT 2002 AUG 19
Bisphosphonates alendronate and ibandronate inhibit artery calcification
at doses comparable to those that inhibit bone resorption
Price PA, Faus SA, Williamson MK
Department of Biology, University of California, San Diego, USA
ARTERIOSCLER THROMB VASC BIOL 2001; 21(5): 817-24
The effect of bone remodeling inhibition by zoledronic acid in an animal
model of cartilage matrix damage
Muehleman C, Green J, Williams JM et al.
Department of Anatomy, Rush Medical College, Chicago, Illinois, USA
OSTEOARTHRITIS CARTILAGE 2002; 10(3): 226-33
Effect of bisphosphonates on cartilage turnover assessed with a newly developed
assay for collagen type II degradation products
Lehmann HJ, Mouritzen U, Christgau S et al.
Centre for Clinical and Basic Research, Ballerup, Denmark Osteometer
Biotech A/S, Herlev, Denmark
ANN RHEUM DIS 2002; 61(6): 530-3
AGGIORNAMENTO DELLA LETTERATURA
Questo aggiornamento della letteratura elenca i lavori riguardanti
i bisfosfonati pubblicati negli ultimi mesi sulle più
importanti riviste scientifiche internazionali.
|
